Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?-Reference-Cited by-同舟云学术

Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?

Published:2020-12 Issue: Volume:150 Page:209-215
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Joosten Pieter J.M.,Dickhoff Chris,van der Noort Vincent^ORCID,Klomp Houke M.^ORCID,van Diessen Judi N.A.^ORCID,Dahele Max^ORCID,Bahce Idris^ORCID,Veenhof Alexander A.F.A.,Smit Egbert F.,Hartemink Koen J.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Special treatment issues in non-small cell lung cancer: diagnosis and managment of lung cancer, 3rd ed: American College of Chest Physicicans evicance-based clinical practice guidelines;Kozower;Chest,2013

2. Concurrent chemoradiotherapy in non-small lung cancer;O’Rourke;Cochrane Databese Syst. Rev.,2010

3. Early-stage and locally advanced (non-metastatic) non-small-cell lung cancer: esmo clinical practice guidelines;Postmus;Ann. Oncol.,2017

4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

5. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;N. Engl. J. Med.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The analysis of current international recommendations for the treatment of patients with stage III non-small cell lung cancer;Grekov's Bulletin of Surgery;2024-05-19

2. Thoracic Reirradiation with Stereotactic Body Radiation Therapy (SBRT) for Recurrent Advanced Non-Small Cell Lung Cancer (NSCLC);Practical Radiation Oncology;2024-05

3. Unresectable Stage III NSCLC Can Be Reevaluated for Resectability After Initial Treatment;Journal of Thoracic Oncology;2023-09

4. Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC;JTO Clinical and Research Reports;2021-05